Holders — by stockHoldings — by fund
Blue Water Life Science Advisors, LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001789778
$251.6M
disclosed book value
8
positions
45%
largest position share
Positions, as of 2026-09-30
top 8 of 8 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | CDNACAREDX INC | 1.7M | $113.1M | 45% |
| 2 | TXG10X GENOMICS INC | 391,400 | $35.4M | 14.1% |
| 3 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 1.0M | $29.2M | 11.6% |
| 4 | GHGUARDANT HEALTH INC | 151,747 | $27.1M | 10.8% |
| 5 | NTRANATERA INC | 34,494 | $14.3M | 5.7% |
| 6 | QTRXQUANTERIX CORP | 3.5M | $12.9M | 5.1% |
| 7 | BLLNBILLIONTOONE INC | 104,000 | $11.1M | 4.4% |
| 8 | TEMTEMPUS AI INC | 105,412 | $8.6M | 3.4% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.